Indacaterol / Mometasone Furoate (Atectura Breezhaler)

Long-acting beta2-adrenergic agonist (LABA) and inhaled corticosteroid (ICS) combination for asthma

Indacaterol / Mometasone Furoate (Atectura Breezhaler)

Forms and strengths
Form: TabletStrength: 150 mcg/80 mcg, 150 mcg/160 mcg, 150 mcg/320 mcg (indacaterol/mometasone furoate) per capsule
Print

Indication

  • Atectura Breezhaler is used as a once-daily maintenance treatment for asthma in adults and adolescents 12 years of age and older whose disease is not adequately controlled on an inhaled corticosteroid alone, or whose severity requires both a LABA and an ICS.
  • Atectura Breezhaler is not meant for patients who only occasionally need a fast-acting reliever inhaler or who are well controlled on an inhaled corticosteroid alone.
  • Atectura Breezhaler does not relieve sudden asthma symptoms and is not a rescue inhaler.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.